#TogetherAgainstFlu Campaign
The #TogetherAgainstFlu online campaign aims to keep raising awareness of the importance of flu vaccinations for healthcare workers, older adults and patients living with chronic conditions.
Read more
Last flu season was exceptionally mild because of the measures used to contain COVID-19, like physical distancing and masks. But what will the upcoming flu season look like?
Read moreThe #TogetherAgainstFlu online campaign aims to keep raising awareness of the importance of flu vaccinations for healthcare workers, older adults and patients living with chronic conditions.
Read more
The Certificate of Pharmaceutical Product (CPP) is a document issued by a country’s regulatory authority at the request of a product owner to support the registration process of a pharmaceutical product of another regulatory authority in a different country. IFPMA's work on CPP focuses on the benefits of this tool as a reliance tool.
Read more28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced today a three-year partnership to strengthen capacity for health innovation in Africa. The two organizations will combine forces to focus on driving capacity strengthening for drug discovery and development in Africa by scaling existing initiatives and...
Read moreThe global burden of neglected tropical diseases (NTDs) affects over 1.7 billion people living in poverty, predominantly in South America, Africa and Asia.
Read moreWith the world’s gaze focused on ramping up production and delivery of 11 billion safe and effective COVID-19 vaccine doses within a year, it is important that we turn an eye to the future. As we need to make provisions for adequate contact tracing and access to diagnosis and treatment all around the world, disease...
Read moreThis five-minute animated video explains the public health implications of the Nagoya Protocol and the importance of timely and unrestricted access to samples and data on pathogens, especially as part of any pandemic response.
Read more
Innovative biopharmaceutical companies are at the forefront of the response to the pandemic; not least by developing and manufacturing COVID-19 vaccines in record time. Our industry joins today’s global summit to demonstrate our commitment towards working with governments and global health partners to align on a common vision to expand and enhance our shared efforts...
Read moreStatement delivered by Thomas Cueni at the Global COVID-19 Summit: Ending the Pandemic and Building Back Better convened by the White House on 22 September 2021.
Read moreGeneva / New York, 21 September 2021: In the margins of the 76th Session of the UN General Assembly and as the world continues to grapple with the ongoing COVID-19 pandemic, IFPMA and the biopharmaceutical industry would like to underscore its commitment to working alongside governments worldwide to combat this unprecedented crisis. Unparalleled collaboration among...
Read moreLast week we convened another media briefing on the biopharmaceutical industry’s efforts to ramp up manufacturing capacity for COVID-19 vaccines, treatments and supplies. We were joined by CEOs and executives from Pfizer, Roche, Merck, Johnson & Johnson, whose 3 main take-aways I would like to share with you. The historic COVID-19 manufacturing scale up has...
Read moreDakar, Senegal, 16 September 2021– The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Speak Up Africa, have announced Conrad Tankou, CEO, GIC Space (Cameroon); John Mwangi, CEO, Daktari Media (Kenya) and Imodoye Abioro, CEO, Healthbotics (Nigeria) as the winners of the Africa Young Innovators for Health Award. The Africa Young Innovators for...
Read more